Tema Oncology ETF — Company Overview, News & Financial Data

Tema Oncology ETF (NASDAQ:CANC) provides investors with exposure to companies actively involved in the fight against cancer. Launched in 2023, CANC invests in a diversified portfolio of global businesses focused on cancer prevention, diagnosis, treatment, and supportive care. This includes pharmaceutical companies developing innovative drugs, medical device manufacturers, and companies providing diagnostic tools and services. By investing in CANC, investors can gain potential access to the long-term growth prospects of the rapidly evolving oncology sector.